Sasol Stock Price, News & Analysis

Sasol reported strong financial results for the year ended June 30, 2022, driven by higher crude oil and chemical prices. Adjusted EBITDA is expected to rise by 36% to 56%, reaching R66 to R75.6 billion. Earnings per share (EPS) are projected to increase over 100%, from R14.57 to between R60.59 and R63.51. However, operational challenges reduced production levels, affecting overall performance. Significant non-cash adjustments include unrealized losses of R5.2 billion, though notable gains were realized from divestments. Detailed annual results will be released on August 23, 2022.

Sasol ecoFT announces its commitment to advancing decarbonization through its proprietary Fischer-Tropsch (FT) technology, capable of producing sustainable fuels and chemicals. With a significant portion of global CO₂ emissions arising from hard-to-abate sectors such as aviation and shipping, Sasol aims to leverage green hydrogen and bio-based carbon to mitigate these emissions. The company highlights that existing synthetic aviation fuels are already accredited, positioning FT technology as a key player in the Sustainable Aviation Fuels market by 2035. Partnerships with industry leaders further support Sasol's goal of transitioning to net zero.

Sasol has published its production and sales performance metrics for the year ended 30 June 2022. The update includes a force majeure declaration on petroleum product supply due to crude oil shipment delays affecting Natref operations; however, restoration of supply is underway with production capacity expected to recover by the end of July 2022. Sasol is finalizing its financial year-end processes and will release its annual financial results on 23 August 2022. Investors are encouraged to attend an upcoming conference call for detailed insights.

Sasol's subsidiary, SSA, has completed a transaction selling a 30% equity interest in the ROMPCO pipeline to iGAS and Companhia Mocambiçana de Gasoduto, after exercising pre-emptive rights. The deal is valued at R4.1 billion, with a potential deferred payment of R1 billion by June 2024, contingent upon meeting specific milestones. Following the sale, Sasol retains a 20% interest in ROMPCO and will continue operational oversight. This divestment aligns with Sasol's ongoing asset divestment strategy initiated in March 2020, reaffirming its commitment to the integrated natural gas sector in Southern Africa.

Sasol Chemicals and LOTTE Chemical are conducting a pre-feasibility study to build a facility for producing battery-grade electrolyte solvents, essential for lithium-ion batteries used in electric vehicles. The study will evaluate locations in Lake Charles, USA, and Marl, Germany, leveraging feedstock from Sasol and proprietary technologies from both companies. The initiative aims to meet increasing battery demand while focusing on sustainability and minimizing carbon footprints through renewable energy usage.

On May 24, 2022, Sasol (NYSE: SSL) announced the launch of the CARE-O-SENE project in Johannesburg, aiming to develop advanced catalysts for sustainable aviation fuels (SAF). Funded by the German Federal Ministry and Sasol, this three-year initiative involves key partners, including Helmholtz-Zentrum Berlin and several research institutions. Aimed at commercializing green kerosene production by 2025, the project utilizes Fischer-Tropsch technology to enhance fuel yield over 80%. This collaboration seeks to support the aviation sector's decarbonization efforts.

Sasol ecoFT has signed a letter of intent with Sollefteå municipality and Uniper to explore building a sustainable aviation fuel production facility in Sweden. The project, under the joint venture SkyFuelH2, aims to utilize green hydrogen and biomass carbon using Sasol's Fischer-Tropsch technology. The selected site in Långsele is optimal due to its renewable energy supply and land availability. Fleetwood Grobler, CEO, emphasizes their commitment to sustainable fuel production. The initiative is viewed as pivotal for the aviation industry's green transition.

Sasol Ltd. (NYSE: SSL) has entered a partnership with Holiferm Limited to develop and commercialize new biosurfactants, specifically sophorolipids. Sasol will purchase the majority of these biosurfactants from Holiferm's upcoming UK manufacturing facility, slated to begin operations in early 2023. This collaboration aims to address the rising demand for sustainable surfactants, utilizing bio-based raw materials to significantly reduce carbon footprints. Financial terms of the agreement remain undisclosed.